• AAPL 189.82
  • TSLA 177.46
  • AMZN 184.7
  • MSFT 420.21
  • INTC 31.85
  • EURUSD 1.0872
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. MX /
  3. JNJ.MX

Johnson & Johnson (JNJ MX) stock market data APIs

₱2559.71 -0.29(-0%) as of May 17, 2024

Johnson & Johnson Financial Data Overview

2560
2559.71
-
2560
2550
2443.01-2933.0214
6 208 999 M
22.7799
2 407 M
85 648 M
29.262
0.0324
0.547
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'JNJ',
Type: 'Common Stock',
Name: 'Johnson & Johnson',
Exchange: 'MX',
CurrencyCode: 'MXN',
CurrencyName: 'Mexican Peso',
CurrencySymbol: '₱',
CountryName: 'Mexico',
CountryISO: 'MX',
OpenFigi: NULL,
ISIN: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - General',
}

Johnson & Johnson Fundamental Data is available in our Financial Data APIs

  • Net Revenue 85 648 M
  • EBITDA 30 613 M
  • Earnings Per Share 112.38
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Johnson & Johnson Earnings via APIs

  • Latest Release 2024-03-12
  • EPS/Forecast NaN

Get Johnson & Johnson End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Johnson & Johnson latest news via APIs

Johnson & Johnson Insiders Sell US$6.8m Of Stock, Possibly Signalling Caution

The fact that multiple Johnson & Johnson (NYSE:JNJ) insiders offloaded a considerable amount of shares over the past year could have raised some eyebrows amongst investors. When analyzing insider tran...

J&J-backed startup Rapport files for US IPO

(Reuters) - Biopharmaceutical company Rapport Therapeutics, backed by the venture capital arm of Johnson & Johnson, filed for an initial public offering in the United States on Friday. Rapport, which...
Do you have any questions?
support@eodhistoricaldata.com